Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device
BackgroundPericardial effusion (PE) is an uncommon but serious complication that occurs following percutaneous left atrial appendage closure (LAAC). There are few data regarding PE following implantation of the LAmbre device for LAAC.MethodsPatients with nonvalvular atrial fibrillation (AF) undergoi...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1188322/full |
| _version_ | 1797810538288250880 |
|---|---|
| author | Yibo Yu Yibo Yu Huimin Chu Huimin Chu Binhao Wang Binhao Wang Bin He Bin He Guohua Fu Guohua Fu |
| author_facet | Yibo Yu Yibo Yu Huimin Chu Huimin Chu Binhao Wang Binhao Wang Bin He Bin He Guohua Fu Guohua Fu |
| author_sort | Yibo Yu |
| collection | DOAJ |
| description | BackgroundPericardial effusion (PE) is an uncommon but serious complication that occurs following percutaneous left atrial appendage closure (LAAC). There are few data regarding PE following implantation of the LAmbre device for LAAC.MethodsPatients with nonvalvular atrial fibrillation (AF) undergoing percutaneous LAAC using the LAmbre device at the Arrhythmia Center of Ningbo First Hospital from October 2017 to March 2021 were retrospectively reviewed (n = 133). PE was defined as acute if diagnosed ≤7 days post LAAC (n = 3, 2.3%) or delayed if diagnosed >7 days post LAAC (n = 3, 2.3%). The clinical characteristics and procedural data were compared between patients with PE (PE group, n = 6) and without PE (non-PE group, n = 127). The predictors of PE were analyzed by logistic regression.ResultsAll patients with PE recovered following treatment by pericardiocentesis. Patients with PE were found to have a higher incidence of congestive heart failure (50.0% vs. 13.4%, P = 0.044) and had larger measured LAA orifice diameters (33.5 mm ± 6.0 mm vs. 28.3 mm ± 5.2 mm, P = 0.018) and landing zone diameters (27.8 mm ± 4.8 mm vs. 23.9 mm ± 4.8 mm, P = 0.054) compared with those without PE. The diameters of the device umbrellas (31.7 mm ± 5.6 mm vs. 26.9 mm ± 5.0 mm, P = 0.026) and covers (36.3 mm ± 4.6 mm vs. 33.4 mm ± 4.0 mm, P = 0.075) implanted were larger in the PE group compared to the non-PE group. Univariate logistic regression revealed that congestive heart failure (OR = 6.47, 95% CI = 1.21–34.71, P = 0.029) and LAA maximal orifice diameter (OR = 1.22, 95% CI = 1.02–1.45, P = 0.027) were both associated with PE following LAmbre device implantation.ConclusionsIn this single-center experience, both acute and delayed PE were uncommon in patients with AF following LAmbre device implantation. Congestive heart failure and a larger LAA orifice were identified as predictors for the occurrence of PE. |
| first_indexed | 2024-03-13T07:09:14Z |
| format | Article |
| id | doaj.art-0305ae1ba2a8428baa19b3df12a97ebe |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-03-13T07:09:14Z |
| publishDate | 2023-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-0305ae1ba2a8428baa19b3df12a97ebe2023-06-06T04:32:59ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-06-011010.3389/fcvm.2023.11883221188322Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre deviceYibo Yu0Yibo Yu1Huimin Chu2Huimin Chu3Binhao Wang4Binhao Wang5Bin He6Bin He7Guohua Fu8Guohua Fu9Arrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaKey Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaArrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaKey Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaArrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaKey Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaArrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaKey Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaArrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaKey Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, ChinaBackgroundPericardial effusion (PE) is an uncommon but serious complication that occurs following percutaneous left atrial appendage closure (LAAC). There are few data regarding PE following implantation of the LAmbre device for LAAC.MethodsPatients with nonvalvular atrial fibrillation (AF) undergoing percutaneous LAAC using the LAmbre device at the Arrhythmia Center of Ningbo First Hospital from October 2017 to March 2021 were retrospectively reviewed (n = 133). PE was defined as acute if diagnosed ≤7 days post LAAC (n = 3, 2.3%) or delayed if diagnosed >7 days post LAAC (n = 3, 2.3%). The clinical characteristics and procedural data were compared between patients with PE (PE group, n = 6) and without PE (non-PE group, n = 127). The predictors of PE were analyzed by logistic regression.ResultsAll patients with PE recovered following treatment by pericardiocentesis. Patients with PE were found to have a higher incidence of congestive heart failure (50.0% vs. 13.4%, P = 0.044) and had larger measured LAA orifice diameters (33.5 mm ± 6.0 mm vs. 28.3 mm ± 5.2 mm, P = 0.018) and landing zone diameters (27.8 mm ± 4.8 mm vs. 23.9 mm ± 4.8 mm, P = 0.054) compared with those without PE. The diameters of the device umbrellas (31.7 mm ± 5.6 mm vs. 26.9 mm ± 5.0 mm, P = 0.026) and covers (36.3 mm ± 4.6 mm vs. 33.4 mm ± 4.0 mm, P = 0.075) implanted were larger in the PE group compared to the non-PE group. Univariate logistic regression revealed that congestive heart failure (OR = 6.47, 95% CI = 1.21–34.71, P = 0.029) and LAA maximal orifice diameter (OR = 1.22, 95% CI = 1.02–1.45, P = 0.027) were both associated with PE following LAmbre device implantation.ConclusionsIn this single-center experience, both acute and delayed PE were uncommon in patients with AF following LAmbre device implantation. Congestive heart failure and a larger LAA orifice were identified as predictors for the occurrence of PE.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1188322/fullpericardial effusionpredictorLAmbreleft atrial appendage closureatrial fibrillation |
| spellingShingle | Yibo Yu Yibo Yu Huimin Chu Huimin Chu Binhao Wang Binhao Wang Bin He Bin He Guohua Fu Guohua Fu Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device Frontiers in Cardiovascular Medicine pericardial effusion predictor LAmbre left atrial appendage closure atrial fibrillation |
| title | Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device |
| title_full | Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device |
| title_fullStr | Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device |
| title_full_unstemmed | Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device |
| title_short | Pericardial effusion following percutaneous left atrial appendage closure using the LAmbre device |
| title_sort | pericardial effusion following percutaneous left atrial appendage closure using the lambre device |
| topic | pericardial effusion predictor LAmbre left atrial appendage closure atrial fibrillation |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1188322/full |
| work_keys_str_mv | AT yiboyu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT yiboyu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT huiminchu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT huiminchu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT binhaowang pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT binhaowang pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT binhe pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT binhe pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT guohuafu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice AT guohuafu pericardialeffusionfollowingpercutaneousleftatrialappendageclosureusingthelambredevice |